Mutations in the IDH1 genes were first identified in malignant gliomas[11,12] and subsequently IDH1 mutations were frequently found in AML[9] and later also recurrent IDH2 mutations were found in AML[13-15]. Here, IDH2 is linked to acute myeloid leukemia.